Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.

CONCLUSIONS: Hypo-WBI in 3 weeks allows excellent oncologic outcomes for invasive breast cancer after conservative surgery. Patients with intraductal carcinoma should be treated with Hypo-WBI only within a controlled study. TRIAL REGISTRATION: IRE-IFO Ethical and Scientific Committee (cod. RS61/04). PMID: 29282078 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29282078?dopt=Abstract

Source: Clinical Genitourinary Cancer - December 27, 2017 Category: Cancer & Oncology Authors: Pinnarò P, Giordano C, Farneti A, Faiella A, Iaccarino G, Landoni V, Giannarelli D, Vici P, Strigari L, Sanguineti G Tags: J Exp Clin Cancer Res Source Type: research